DUBLIN, Mar 30, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Anatomic Pathology Market - Forecasts to 2021" report to their offering.
The anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1%.
The global anatomic pathology market is segmented on the basis of product & service and application. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.
On the basis of product and service, the market is segmented into instruments, consumables, and services. In 2016, the services segment accounted for the largest share of the market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.
On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and others applications. In 2016, the disease diagnosis segment accounted for the largest share of the market. The growth in this segment primarily attributed to increasing prevalence of chronic diseases.
The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China, India, and Japan; the large population and rising prevalence of chronic diseases in these countries; improving standards of living; growing demand for quality medical care; increasing healthcare spending and government initiatives; rising awareness about the use of anatomic pathology tests among physicians; and growth in the demand for diagnostics are some major factors driving the high growth of this regional segment.
- Agilent Technologies, Inc.
- Bio SB
- Biogenex Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche AG.
- Laboratory Corporation of America Holdings
- Neogenomics Laboratories, Inc.
- Quest Diagnostics Incorporated
- Sakura Finetechnical Co.
- Thermo Fisher Scientific
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Anatomic Pathology Market, By Product & Service
7 Anatomic Pathology Market, By Application
8 Anatomic Pathology Market, By Region
9 Competitive Landscape
10 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/8kgrzd/anatomic
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/anatomic-pathology-market-to-reach-219-billion-usd-by-2021---witnessing-high-growth-due-to-increasing-prevalence-of-chronic-diseases--increasing-healthcare-expenditure---research-and-markets-300431724.html
SOURCE Research and Markets